Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
49 Cards in this Set
- Front
- Back
Drugs that contain carboxylic acid groups (-COOH) can sometimes form esters with a fatty substance present in the body. The metabolite is not readily excreted. Name the fatty substance, and the enzyme that catalyzes the reaction.
|
Cholesterol. Ester hydrolase.
|
|
Efflux transport of drug metabolite is sometimes called _____________ of drug metabolism.
|
phase III
|
|
Do all drugs interact only with their respective receptors? Why or why not?
|
No. May have structure similar to interacting at other receptors so good chance it will also interact somewhat at other receptors.
|
|
Name one way an alcohol might be metabolized.
|
Oxidation
|
|
State how biotransformation usually affects the physio-chemical properties of the drug.
|
Increases the water solubility.
|
|
Give the definition of Phase I reactions of drug molecules.
|
Phase I reactions introduce or uncover a functional group/s in the drug molecule.
|
|
Give 5 examples of classes of chemicals that are considered xenobiotics.
|
Therapeutic drugs
Food additives Drugs of abuse Pesticides Household chemicals |
|
Explain who it is important as pharmacists and as a member of the health care team, to understand drug biotransformation.
|
The rate and extent of drug biotransformation will determine the duration of action of a drug. This will affect how often the drug is taken.
|
|
Enzymes of biotransformation often have _____ affinity for their drug substrates.
|
low
|
|
There are many individual forms of cytochrome P450 enzymes in the human liver. State one feature that all of these enzymes have in common and why it is important.
|
All contain a heme-iron prosthetic group. This is the site of oxygen binding and drug oxidation.
|
|
State one way in which individual cytochrome P450 enzymes differ from one another and what effect does this difference have on how each of the enzymes work.
|
The individual cytochrome P450 enzymes have different primary amino acid sequences. Each has a somewhat different substrate selectivity.
|
|
Considering the major prescription drugs today, which phase I enzyme is the most important in their biotransformation?
|
CYP 3A4
|
|
Briefly define phase II reactions.
|
A functional group in the drug (or any drug metabolite) is combined with a small, usually polar and water-soluble, endogenous molecule to form a conjugated metabolite. The phase II metabolite is often anionic at physiological pH and readily excreted.
|
|
Glucuronidation and sulfation pathways often compete for the same substrat. State the conditions under which glucuronidation may be expected to be the predominant pathway.
|
If the dose of the drug leads to a high concentration in the liver, then glucuronidation is expected to predominate. This is because although UGT has a low affinity for drugs, it has a high capacity and also because the co-substrate UDP-GA is abundant and readily synthesized. In contrast, sulfonation is often saturated because of a low availability of PAPS and the difficulty of synthesizing PAPS.
|
|
Drugs that contain aliphatic hydroxyl groups (-OH) can sometimes form esters with a fatty acid substance present in the body. The metabolite is not readily excreted. Name the fatty substance, and the enzyme that catalyzes the reaction.
|
Fatty acid. Ester hydrolase.
|
|
____________ adds to another molecule or functional group.
|
Conjugation
|
|
____________ adds water.
|
Hydrolysis
|
|
____________ adds oxygen in various forms.
|
Oxidation
|
|
____________ adds alkyl groups.
|
Alkylation
|
|
Explain what is meant by the term "drug biotransformation."
|
Conversion of a drug to a metabolite by an enzymatic process.
|
|
Give an example of a xenobiotic.
|
Therapeutic drug, food additive, small organic molecule not needed for physiological purposes, pesticide, or an environmental pollutant
|
|
What physio-chemical property of a drug is usually changed following the process of drug biotransformation?
|
The water solubility of the drug is usually increased following biotransformation.
|
|
Phase I reactions ____________ or ___________ functional groups in drug molecules.
|
introduce. uncover.
|
|
State another name for phase II reactions of drug biotransformation.
|
Conjugation reactions
|
|
True/False
Enzymes of drug biotransformation usually have a very high affinity for their substrates. |
False. low.
|
|
The most abundant form of cytochrome P450 in the human liver is CYP3A4. Explain what this terminology means.
|
CYP is the abbreviation for cytochrome P450, a heme-thiolate protein. 3 is the family this particular protein belongs to. To be in a family, proteins must have an amino acid primary sequence that is at least 40% similar to other family members. A is the sub-family. To be in a sub-family, proteins must be at least 55% similar. 4 is the actual P450 proteins with >97% sequence identity and are considered the same protein.
|
|
Name 4 functional groups that are commonly found in drug molecules and that can undergo hydrolysis to uncover new functional groups.
|
Ester
Amide Peptide Epoxide |
|
State three phase II pathways that are quantitatively most important for widely used therapeutic drugs. Which of these three pathways is likely to be rate-limited by the availability of co-substrate in the cell?
|
Glucuronidation
Sulfonation - Likely to be limited by co-substrate availability in the cell Glutathione conjugation |
|
The endogenous tripeptide ______________ reacts with electrophilic centers in drug molecules. The product is not excreted directly, but is further metabolized in ________________ additional steps (not including the first step) to an N-acetyl-cysteine conjugate, also known as a _______________ acid.
|
glutathione
three mercapturic |
|
The usual effect of xenobiotic biotransformation is to convert a _____________ drug into a water-soluble metabolite that is more readily _______________ from the body.
|
lipophilic
excreted |
|
Phase I reactions ______________ or ______________ functional groups in drug molecules.
|
introduce
uncover |
|
As well as the protein, what other components of the enzyme cytochrome P450 are vital for the enzyme to have catalytic activity.
|
Iron
Heme prosthetic group |
|
Define phase II biotransformation.
|
Combine functional groups in the drug with small, usually polar molecule.
|
|
The co-substrate for acetylation is _______________ and the cosubstrate for methylation is ________________.
|
acetyl CoA
S-adenosyl-methionine (SAM) |
|
Drugs that contain electrophilic centers can be detoxified by conjugation with the tripeptide _________________. These conjugates must be further metabolized to _________________ _________________
|
glutathione
mercapturic acids |
|
Two drugs that contain hydroxyl groups are orally active. The effective dose for one drug is 1500 mg and the effective dose for the other drug is 5 mg. Predict the likely urinary metabolites of each drug. What factors with influence which metabolites are formed?
|
1500 mg - Glucuronide
5 mg - Sulfate Affinity of drugs for sulfotransferase versus UDP-glucuronyltransferase. Availability of cosubstrate, PAPS and UDP-GA. PAPS - Limited availability, difficult to synthesize. UDP-GA - High availability, easy to synthesize. |
|
Name a phase 2 reaction that results in a less water soluble product than the parent drug.
|
Methylation, fatty acid conjugation or cholesterol conjugation.
|
|
Name four biological processes that are influenced by chemical structure (lipid solubility)
|
Absorption
Metabolism Excretion Biological activity |
|
Do all drugs interact only with their respective receptors?
|
No.
|
|
A xenobiotic that is ________________ is readily absorbed after oral administration, but has to be converted to a more _________________ metabolite to be eliminated from the body.
|
Lipophilic
Hydrophilic |
|
In what way do phase I reactions alter drug molecules?
|
Introduce or uncover a functional group
|
|
In phase II biotransformation reactions, a drug's _________________ group is combined with a small, usually polar _________________ molecule. The metabolic product is often an _________________ at physiological pH.
|
functional
endogenous anion |
|
The co-substrate for glucuronidation is ___________________ and the co-substrate for methylation is ___________________.
|
UDP-glucuronic acid
S-adenosylmethionine. |
|
What general physio-chemical property do drug molecules that are effective orally share?
|
They are lipophilic
|
|
What is the overall effect of biotransformation pathways on this property?
|
Biotransformation increases water solubility and decreases lipid solubilty
|
|
Briefly define phase I and phase II biotransformation reactions.
|
Phase I reactions introduce or uncover function groups.
Phase II reactions combine the drug's functional group with a small, usually polar, endogenous molecule. |
|
State two ways in which drug-metabolizing enzymes are different from enzymes involved in intermediary metabolism.
|
Broad substrate specificity. Low affinity for the enzyme.
|
|
The co-substrate for sulfation is ______________ and the co-substrate for acetylation is _________________.
|
PAPS
acetyl CoA |
|
The tripeptide ___________________ is important in the phase II detoxification of electrophilic centers in drugs. An example of an electrophilic center is the ____________________ group. This reaction is catalyzed by the enzyme ___________________. The conjugate formed by this reaction is not excreted itself, but is further metabolized to a __________________ __________________, which is readily excreted because it is anionic at physiological pH.
|
glutathione
alkyl halide, epoxide, or quinone imine glutathione S-transferase mercapturic acid |